Our top pick for
Stepan Company is a specialty chemicals business based in the US. Stepan Company shares (SCL) are listed on the NYSE and all prices are listed in US Dollars. Stepan Company employs 2,293 staff and has a trailing 12-month revenue of around USD$1.9 billion.
|52-week range||USD$68.7975 - USD$131.72|
|50-day moving average||USD$121.5124|
|200-day moving average||USD$118.1341|
|Wall St. target price||USD$140.5|
|Dividend yield||USD$1.13 (0.93%)|
|Earnings per share (TTM)||USD$5.45|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Stepan Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stepan Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stepan Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Stepan Company shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Stepan Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.34. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stepan Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stepan Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$240.4 million.
The EBITDA is a measure of a Stepan Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.9 billion|
|Operating margin TTM||8.48%|
|Gross profit TTM||USD$365.6 million|
|Return on assets TTM||5.95%|
|Return on equity TTM||13.57%|
|Market capitalisation||USD$2.7 billion|
TTM: trailing 12 months
There are currently 328,211 Stepan Company shares held short by investors – that's known as Stepan Company's "short interest". This figure is 2.3% down from 336,085 last month.
There are a few different ways that this level of interest in shorting Stepan Company shares can be evaluated.
Stepan Company's "short interest ratio" (SIR) is the quantity of Stepan Company shares currently shorted divided by the average quantity of Stepan Company shares traded daily (recently around 75974.768518519). Stepan Company's SIR currently stands at 4.32. In other words for every 100,000 Stepan Company shares traded daily on the market, roughly 4320 shares are currently held short.
However Stepan Company's short interest can also be evaluated against the total number of Stepan Company shares, or, against the total number of tradable Stepan Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stepan Company's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Stepan Company shares in existence, roughly 10 shares are currently held short) or 0.0206% of the tradable shares (for every 100,000 tradable Stepan Company shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stepan Company.
Find out more about how you can short Stepan Company stock.
Dividend payout ratio: 20.46% of net profits
Recently Stepan Company has paid out, on average, around 20.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stepan Company shareholders could enjoy a 1% return on their shares, in the form of dividend payments. In Stepan Company's case, that would currently equate to about $1.13 per share.
While Stepan Company's payout ratio might seem low, this can signify that Stepan Company is investing more in its future growth.
Stepan Company's most recent dividend payout was on 15 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 4 March 2021 (the "ex-dividend date").
Stepan Company's shares were split on a 2:1 basis on 17 December 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stepan Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stepan Company shares which in turn could have impacted Stepan Company's share price.
Over the last 12 months, Stepan Company's shares have ranged in value from as little as $68.7975 up to $131.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stepan Company's is 0.7295. This would suggest that Stepan Company's shares are less volatile than average (for this exchange).
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in the food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northfield, Illinois.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.